Bioventix Cash Flow Statement

Financials in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	7.58	8.1	8.37	7.67	6.73
Depreciation & Amortization	0.09	0.11	0.13	0.14	0.14
Stock-Based Compensation	0.09	0.09	0.17	0.24	0.26
Other Adjustments	2.32	2.49	1.66	1.62	1.36
Change in Receivables	-0.03	-0.39	-0.63	-0.6	-0.98
Changes in Inventories	-0.07	-0.05	-0.1	-0.13	-0.09
Changes in Accounts Payable	-0.1	0.08	-0.05	0.08	0.06
Changes in Income Taxes Payable	-2.85	-2.08	-1.75	-1.47	-1.14
Operating Cash Flow	7.03	8.34	7.8	7.56	6.34
Operating Cash Flow Growth	-15.73%	6.94%	3.25%	19.25%	-17.51%
Capital Expenditures	-0.02	-0.02	-0.01	-0.01	-0.26
Sale of Property, Plant & Equipment	-	-	-	-	0
Other Investing Activities	0.19	0.2	0.1	0	0.03
Investing Cash Flow	0.17	0.19	0.09	-0.01	-0.23
Issuance of Common Stock	0.07	-	0.14	-	0.02
Net Common Stock Issued (Repurchased)	0.07	-	0.14	-	0.02
Common Dividends Paid	-8.19	-8.25	-8.44	-7.92	-7.71
Other Financing Activities	-	-	-	-0	-
Financing Cash Flow	-8.12	-8.25	-8.3	-7.92	-7.69
Net Cash Flow	0.92	-0.28	-0.41	-0.37	-1.58
Free Cash Flow	7.01	8.33	7.79	7.55	6.08
Free Cash Flow Growth	-15.80%	6.88%	3.27%	24.16%	-17.24%
FCF Margin	53.47%	61.21%	60.80%	64.38%	55.60%
Free Cash Flow Per Share	1.32	1.57	1.47	1.43	1.15
Levered Free Cash Flow	4.64	6.15	6.58	6.28	5.44
Unlevered Free Cash Flow	4.49	6.13	6.5	6.28	5.41

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.